Pharmacokinetics and Pharmacodynamics Study

Clinical trial NCT07074236 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07074236
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C

Start date: 2025-07-01
Primary completion: 2026-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.